DD266349A5 - Verfahren zur herstellung von 2-acyloxypropylamin-2-acyloxypropylamin-derivaten - Google Patents

Verfahren zur herstellung von 2-acyloxypropylamin-2-acyloxypropylamin-derivaten Download PDF

Info

Publication number
DD266349A5
DD266349A5 DD87305485A DD30548587A DD266349A5 DD 266349 A5 DD266349 A5 DD 266349A5 DD 87305485 A DD87305485 A DD 87305485A DD 30548587 A DD30548587 A DD 30548587A DD 266349 A5 DD266349 A5 DD 266349A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
compounds
sulfur
acyloxypropylamine
carbon atoms
Prior art date
Application number
DD87305485A
Other languages
German (de)
English (en)
Inventor
Uwe Trostmann
Christoph Schaechtele
Karl Mannhardt
Claus Rudolph
Dieter Marme
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD266349A5 publication Critical patent/DD266349A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
    • C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Monitoring And Testing Of Nuclear Reactors (AREA)
  • Hydrogenated Pyridines (AREA)
  • Breakers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measurement Of Force In General (AREA)
DD87305485A 1986-07-30 1987-07-29 Verfahren zur herstellung von 2-acyloxypropylamin-2-acyloxypropylamin-derivaten DD266349A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863625738 DE3625738A1 (de) 1986-07-30 1986-07-30 2-acyloxypropylamin-derivate, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
DD266349A5 true DD266349A5 (de) 1989-03-29

Family

ID=6306287

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87305485A DD266349A5 (de) 1986-07-30 1987-07-29 Verfahren zur herstellung von 2-acyloxypropylamin-2-acyloxypropylamin-derivaten

Country Status (17)

Country Link
US (1) US4855489A (xx)
EP (1) EP0255126B1 (xx)
JP (1) JPS6348250A (xx)
KR (1) KR880001577A (xx)
AT (1) ATE81499T1 (xx)
AU (1) AU597090B2 (xx)
CA (1) CA1318670C (xx)
DD (1) DD266349A5 (xx)
DE (2) DE3625738A1 (xx)
DK (1) DK374887A (xx)
ES (1) ES2052525T3 (xx)
FI (1) FI89042C (xx)
GR (1) GR3006081T3 (xx)
HU (1) HU197720B (xx)
IL (1) IL83368A (xx)
SU (1) SU1470177A3 (xx)
ZA (1) ZA875640B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705384A1 (de) * 1987-02-20 1988-09-01 Goedecke Ag 2-propylamin-derivate, verfahren zu deren herstellung sowie deren verwendung
EP0296545B1 (de) * 1987-06-25 1992-03-04 Hoechst Aktiengesellschaft Ein neues Antibiotikum, Fumifungin, ein mikrobielles Verfahren zu seiner Herstellung und seine Verwendung als Arzneimittel
DE3836987A1 (de) * 1988-10-31 1990-05-23 Goedecke Ag 2-aminocarbonsaeuren und deren derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
GB2321455A (en) 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
US7476656B2 (en) * 2004-11-09 2009-01-13 University Of Florida Research Foundation, Inc. Fluorescent affinity tag to enhance phosphoprotein detection and characterization
US8930331B2 (en) 2007-02-21 2015-01-06 Palantir Technologies Providing unique views of data based on changes or rules
US9092482B2 (en) 2013-03-14 2015-07-28 Palantir Technologies, Inc. Fair scheduling for mixed-query loads

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU66207A1 (xx) * 1972-09-29 1974-04-02
CH618958A5 (en) * 1975-07-01 1980-08-29 Ciba Geigy Ag Process for the preparation of novel secondary acyloxyamines
DE2820892A1 (de) * 1978-05-12 1979-11-22 Nattermann A & Cie Neue strukturanaloga von glyveriden und verfahren zu deren herstellung
GB2172284B (en) * 1985-03-12 1988-07-27 Ciba Geigy Ag Nitrogen-containing additives for non-aqueous functional fluids

Also Published As

Publication number Publication date
DK374887A (da) 1988-01-31
GR3006081T3 (xx) 1993-06-21
ES2052525T3 (es) 1994-07-16
EP0255126A2 (de) 1988-02-03
SU1470177A3 (ru) 1989-03-30
DE3782207D1 (de) 1992-11-19
HUT44228A (en) 1988-02-29
EP0255126B1 (de) 1992-10-14
FI873313A (fi) 1988-01-31
IL83368A (en) 1991-05-12
JPS6348250A (ja) 1988-02-29
FI89042C (fi) 1993-08-10
CA1318670C (en) 1993-06-01
IL83368A0 (en) 1987-12-31
DK374887D0 (da) 1987-07-17
AU7624887A (en) 1988-02-04
HU197720B (en) 1989-05-29
US4855489A (en) 1989-08-08
DE3625738A1 (de) 1988-02-11
ATE81499T1 (de) 1992-10-15
FI89042B (fi) 1993-04-30
FI873313A0 (fi) 1987-07-29
KR880001577A (ko) 1988-04-25
ZA875640B (en) 1988-11-30
AU597090B2 (en) 1990-05-24
EP0255126A3 (en) 1989-01-11

Similar Documents

Publication Publication Date Title
EP0427765B1 (de) Alkoxy-4(1h)-pyridon-derivative, verfahren zu deren herstellung und deren verwendung als arzneimittel
EP0026848B1 (de) Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten
DE2705025A1 (de) Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP1289929A1 (de) Verkürzte synthese von 3,3-diarylpropylamin-derivaten
DE1620035A1 (de) 3-Amino-5-X-6-halogenpyrazinonitrile und Verfahren zu deren Herstellung
DD266349A5 (de) Verfahren zur herstellung von 2-acyloxypropylamin-2-acyloxypropylamin-derivaten
DE3781174T2 (de) Verwendung von aromatischen diaminen fuer die behandlung von angina pectoris und diamine dafuer.
DE69105786T2 (de) Harnstoffderivate, deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen.
DE2930440A1 (de) 1-phenyl-piperazinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0367205B1 (de) 2-Aminocarbonsäuren und deren Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
FR2466462A2 (fr) Derives d'alkylenediamines, leur preparation et leur application en therapeutique
DE69620175T2 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
EP0152598B1 (de) Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amin, seine Verwendung zur Herstellung von 1-(3-Hydroxy-propyl)-1,4-diazepan und 1,4 Bis-[3-(3,4,5-trimethoxy-benzoyloxy)-propyl]-diazepan
EP0293814A1 (de) Neue Mono- und Polyhydroxyacyl-Derivate polyoxygenierter Labdane, ein Verfahren zu deren Herstellung und ihre Verwendung als Medikamente
US3345411A (en) 2-alkyl-3, 3-diphenyl-propen-(2)-yl-amines and salts thereof
DE3440295A1 (de) Verfahren zur diastereoselektiven reduktion von 3-amino-1-benzoxepin-5(2h)-onen
EP0152799A1 (en) Compounds having peripheral calcium antagonist, anticonvulsive and eumetabolic activity, processes for the preparation thereof and pharmaceutical compositions containing them
DE69528770T2 (de) Derivate des benzopyrans und des benzothiopyrans, deren herstellung und deren verwendung als agonisten von dopamin rezeptoren
CH605617A5 (en) 2-Aminobenzylamine derivs prepn.
AT400146B (de) Verfahren zur herstellung von 1-(2-((5-
EP0236263A2 (de) Substituierte Pyrrolidinone
AT360549B (de) Verfahren zur herstellung von neuen glycidsaeure- bzw. thioglycidsaeurederivaten und deren salzen
EP0279458A1 (de) 2-Propylamin-Derivate, Verfahren zu deren Herstellung sowie deren Verwendung
DE2720915A1 (de) Neue 1-acyl-2-hydroxy-1,3-diaminopropane, verfahren zur herstellung derselben und arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee